SHELLEY MCHORSE: Open Payments
NPI 1982315925 · FLORESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,852 in 218 payments from 25 companies in 2025. Trend: 2023 $187 · 2024 $2,140 · 2025 $3,852
Food & beverage: $3,852
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $578 |
| PFIZER INC. | 32 | $387 |
| ABBVIE INC. | 29 | $376 |
| Lilly USA, LLC | 14 | $371 |
| Axsome Therapeutics, Inc. | 11 | $298 |
| AstraZeneca Pharmaceuticals LP | 15 | $281 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $257 |
| GlaxoSmithKline, LLC. | 12 | $185 |
| Kowa Pharmaceuticals America, Inc. | 10 | $182 |
| Otsuka America Pharmaceutical, Inc. | 16 | $179 |
Products named: NURTEC ODT, Ozempic, Kerendia, REXULTI, FARXIGA, QULIPTA, ZORYVE, Auvelity.
Industry payments across TX — which companies pay providers there.
